Skip to main content
OpenTrials

Clinical trial condition

Congenital Bleeding Disorder

Explore clinical trials studying Congenital Bleeding Disorder. Study availability and eligibility vary by location and protocol.

85 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Congenital Bleeding Disorder trial results

Completed

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

NCT06574984

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • National centre for Hamophilia Baghdad, Iraq
  • Novo Nordisk Investigational Site Baghdad, Iraq
  • Basrah Haemoplhilia centre Basra, Iraq
  • Hilla Haemophilia centre Hillah, Iraq
View Trial Details
Completed

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

NCT02141074

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Miller Children's Hospital Long Beach Long Beach, California, United States
  • Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States
  • Shands Hospital at the University of Florida Gainesville, Florida, United States
  • Nemours Chld Clnc Jacksonville Jacksonville, Florida, United States
View all 93 locations
View Trial Details
Completed

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

NCT01467427

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
  • Childrens National Medical Ctr Washington D.C., District of Columbia, United States
View all 51 locations
View Trial Details
Completed

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

NCT02137850

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Arizona H&T Phoenix Child Hosp Phoenix, Arizona, United States
  • Miller Children's Hospital Long Beach Long Beach, California, United States
  • Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States
  • Children's Hosp Of Orange Orange, California, United States
View all 96 locations
View Trial Details
Completed

A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan

NCT02670213

Conditions
Congenital Bleeding Disorder, Congenital FXIII Deficiency
Locations
  • Nagoya University Hospital_Blood Transfusion Aichi, Japan
  • Gamagori Hospital Gamagori-shi, Aichi, Japan
  • Chugoku Central Hospital Hiroshima, Japan
  • Kure Medical Center and Chugoku Cancer Center Kure-shi, Hiroshima, Japan
View Trial Details
Completed

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

NCT01561391

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Completed

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

NCT03075670

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Peoria, Illinois, United States
  • Novo Nordisk Investigational Site East Lansing, Michigan, United States
View Trial Details
Completed

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

NCT03528551

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Long Beach, California, United States
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
  • Novo Nordisk Investigational Site New Orleans, Louisiana, United States
View all 67 locations
View Trial Details

Related conditions